期刊文献+

依贝沙坦对充血性心力衰竭患者心功能的影响 被引量:1

Effects of irbsartan on patients with congestive heart failure
下载PDF
导出
摘要 目的 :观察依贝沙坦 (irbesartan)对充血性心力衰竭(congestiveheartfailure ,CHF)患者心功能的影响 .方法 :按入院时间随机分为治疗组 (A组 ,n =30 )及对照组 (B组 ,n =30 ) .两组常规使用洋地黄、利尿剂、血管扩张剂 .A组加用依贝沙坦 75~ 1 5 0mg·d-1 ,B组加用卡托普利 2 5mg 3·d-1 ,治疗 4~ 6wk ,观察治疗前后心率、血压、心胸比、左室舒张压未期内径 ,左室射血分数以及心功能的变化 .结果 :A组治疗后心率 (次·min-1 ) (1 1 5± 9)vs (83± 1 1 ) ,血压 (kPa)SP :(1 7.4± 1 .8)vs(1 3.4± 1 .5 ) ,DP :(1 1 .5± 0 .8)vs (9.4± 0 .6 ) ;心胸比 (0 .73± 0 .0 5 ) %vs (0 .5 2± 0 .0 3) %以及左室舒张压未期内径 (6 5 .3± 6 .8)mmvs (5 0 .7± 3.9)mm较治疗前均显著下降 (P <0 .0 5 ,P <0 .0 1 ) ,左室射血分数 (0 .38± 0 .0 3) %vs (0 .6 0± 0 .0 5 ) %较治疗前增加 (P <0 .0 1 ) ,心功能改善 .A组治疗后各项指标较B组差异显著 (P <0 .0 5 ,P <0 .0 1 ) .结论 :依贝沙坦对CHF患者心功能有显著改善 ,副作用小 ,值得临床推广 . AIM: To observe the effects of irbsartan in treating patients with congestive heart failure. METHODS: The patients were randomized into therapeutic group A ( n =30) and control group B ( n =30) according to the admission date. The patients in the two groups with congestive heart failure were conventionally treated with such medicines as digitalis, diuretic and vasodilator. Meanwhile irbsartan was given to group A and captopril was given to group B (25 mg, 3·d -1 ) and the pre and post treatment changes were observed of heart rate (HR), blood pressure (BP), cardiothoracic ratio, left ventricular end diastolic diameter (LVEDD), left ventricular ejection fraction and cardiac function after 4~6 weeks' therapy. RESULTS: After being treated for 4~6 weeks, HR (115±9) vs (83±11), BP (SP: (17.4±1.8) vs (13.4±1.5), DP: (11.5±0.8) vs (9.4±0.6), cardiothoracicratio (0.73±0.05) vs (0.52±0.03) and LVEDD of the patients in group A (65.3±6.8) mm vs (50.7±3.9) mm were all obviously reduced ( P < 0.05 , P <0.01), while their left ventricular ejection fraction (0.38±0.03)% vs (0.60±0.05) % was increased ( P < 0.01 ). The cardiac function was improved as compared with that of pro treatment. All the indexes in group A were significantly different as compared with those in group B ( P < 0.05, P <0.01). CONCLUSION: Irbsartan, with few side effects, can remarkably improve the heart function of the patients with congestive heart failure.
机构地区 解放军
出处 《第四军医大学学报》 北大核心 2003年第23期2193-2195,共3页 Journal of the Fourth Military Medical University
关键词 心力衰竭 充血性 依贝沙坦(irbesartan) 血管紧张素Ⅱ heart failure, congestive irbesartan angiotensin II
  • 相关文献

参考文献2

二级参考文献2

共引文献73

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部